Statistics
Total Visits
Views | |
---|---|
The pharmacokinetics pharmacodynamics safety and tolerability of NN2211 a new long-acting GLP-1 derivative in healthy men(legacy) | 105 |
The pharmacokinetics pharmacodynamics safety and tolerability of NN2211 a new long-acting GLP-1 derivative in healthy men(legacy) | 67 |
Total Visits per Month
November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | |
---|---|---|---|---|---|---|---|
The pharmacokinetics pharmacodynamics safety and tolerability of NN2211 a new long-acting GLP-1 derivative in healthy men | 4 | 6 | 1 | 0 | 7 | 1 | 10 |
File Downloads
Views |
---|
Top Country Views
Views | |
---|---|
United States | 65 |
Australia | 18 |
China | 14 |
Netherlands | 9 |
France | 6 |
Vietnam | 5 |
Singapore | 4 |
Argentina | 2 |
United Kingdom | 2 |
Ireland | 1 |
Top City Views
Views | |
---|---|
Ashburn | 25 |
Kaleen | 16 |
Fairfield | 11 |
Rotterdam | 8 |
Boardman | 5 |
Hanoi | 5 |
New York | 5 |
San Jose | 5 |
Hangzhou | 4 |
Singapore | 3 |